Extract
Two interesting publications in theEuropean Respiratory Journalrecently by Russoet al. [1] and Leunget al. [2] discuss the possible role of nicotine in this pandemic and the “furious pursuit for better therapeutics”.
一个bstract
Exogenous supplement of recombinant human (rh)ACE-2 might be a brilliant idea in the treatment of COVID-19. Soluble ACE-2 might impact viral spread, since binding to soluble receptor has been shown to block SARS-CoV-2 entry.https://bit.ly/3bsUKO2
Footnotes
Conflict of interest: D. Lutchman has nothing to disclose.
- ReceivedMay 4, 2020.
- 一个cceptedMay 6, 2020.
- Copyright ©ERS 2020
http://creativecommons.org/licenses/by-nc/4.0/
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.